RegulatoryGuideline · final
MHRA updates London Region I sandbox call with next-stage application details
🇬🇧 MHRA · Wed 18 Nov 2026
The UK regulator has added information on what happens after expressions of interest are screened for its sandbox for AI-enabled medical devices and NHS providers in London.
The Medicines and Healthcare products Regulatory Agency (MHRA) has updated its call for expressions of interest in the London Region I MHRA Regulatory Sandbox. The revision, dated 18 November 2026, adds information on the next stage of the application process, including what happens once expressions of interest have been screened.
Subscribe to keep reading
$4.99 / month
- Every article, analysis and opinion piece on VigiEye and CompePharma
- One subscription for both sites, cancel any time
or
Official guideline text: MHRA ↗
Article written by VigiEye from the official source (MHRA). AI-assisted; check the source before acting.
More Regulatory
All →
EEA Joint Committee extends three EU feed additive rules to Iceland and Norway
🇪🇺 EUR-Lex · Thu 19 Nov 2026
Health Canada lists Class II recall of Stryker's Blueprint shoulder-planning software over two bugs
🇨🇦 Health Canada · Wed 18 Nov 2026
FDA approves Infilbray, first treatment for neurological symptoms of Type 3 Gaucher disease
🇺🇸 FDA · Wed 18 Nov 2026
INFARMED lifts suspension of Limeciclina Atral 408 mg capsules after bioequivalence shown
🇵🇹 INFARMED · Wed 18 Nov 2026
Commission publishes minutes of SCHEER working group meeting on brain stimulators
🇪🇺 European Commission (DG SANTE) · Wed 18 Nov 2026
AIFA reminds sponsors how to pay Annual Safety Report evaluation fee
🇮🇹 AIFA · Wed 18 Nov 2026